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Abstract
Halitosis is a common and ignored condition, but in some, it is a disease-associated
health problem, suggestive of overt disease conditions and hasaffected about 25–30% of
world’s population, bothering nonmedical social disturbance in many people. Although
two kinds, pseudohalitosis and halitophobia, are also concerned, genuine halitosis origi‐
nated from the oral cavity, such as gingivitis, caries, and poor oral hygiene, in 80% and
the remaining 20% are extraoral sources of halitosis, which should not be ignored be‐
cause of stigmata suggestive of overt tissue dysfunctions, for instance, poor nutrition and
hygiene, alcohol abuse, smoking, and systemic illness such as chronic obstructive pulmo‐
nary disease, liver cirrhosis, diabetes mellitus, and chronic renal diseases. In this chapter,
Helicobacter pylori (H. pylori)–associated halitosis as one of the extragastric manifestations
is introduced. Since diagnostics of halitosis includes subjective methods (examiner’s
sense of smell) and objective methods (instrumental analysis), under the hypothesis of a
possible relationship between H. pylori infection and objective halitosis, the real levels of
volatile sulfur compounds (VSCs) in the breath showed significant correlation between
VSC levels and the degree of H. pylori–associated erosive gastritis as well as gastric can‐
cer. These findings are further validated through either measuring H2S level in gastric jui‐
ces of H. pylori–infected gastritis or checking the expressions of cystathionine-γ-lyase
(CSE) and cystathionine-β-synthase (CBS) responsible for H2S generation in biopsied
stomach. The eradication of H. pylori significantly ameliorated halitosis, accompanied
with significant reductions in gastric H2S levels (p<0.01). Korean red ginseng was very ef‐
fective in either reducing H. pylori–associated H2S or alleviating halitosis in patients with
H. pylori–associated chronic atrophic gastritis. Conclusively, H. pylori infection demon‐
strates to have an important relationship with the development of halitosis, and its eradi‐
cation could possibly promote the improvement of this condition.
Keywords: Halitosis, Helicobacter pylori, volatile sulfur compounds, hydrogen sulfide,
gastritis, gastroesophageal reflux disease
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
1. Introduction
1.1. Halitosis, pseudohalitosis, and halitophobia
Halitosis is a very common and unpleasant condition, affecting around 1/4–1/3 of the general
population, which can be classified into the following three conditions, genuine halitosis,
pseudohalitosis,  and halitophobia based on their pathogenesis [1,  2];  genuine halitosis is
usually related to an organic pathology, such as periodontitis, gingivitis, gastritis, and other
systemic illness, and malodor molecules such as volatile sulfur compounds (VSCs) that arise
usually from bacterial  interactions generate the basis of oral  malodor,  such as hydrogen
sulfide (H2S), methyl mercaptan (CH3SH), and dimethyl sulfide [(CH3)2S]. In addition, sulfur
compounds,  short-chain fatty acids,  such as butyric  acid (CH3CH2CH2COOH),  propionic
acid  (CH3CH2COOH),  and  valeric  acid  (C5H10O2),  diamines,  including  cadaverine
[NH2(CH2)5HN2]  and  putrescine  [NH2(CH2)4HN2],  1-proxy-2-propanol,  phenyl  com‐
pounds,  such  as  indole,  skatole,  phyridiene,  alkalines,  ketones,  and  nitrogen-containing
compounds, such as urea [(NH2)2CO2] and ammonia (NH3), may contribute to malodor of
halitosis  [3,  4].  When the  concentration of  these  molecules  in  halitotic  breath  exceeds  a
threshold  detected  by  objective  methods,  genuine  halitosis  can  be  diagnosed.  Further‐
more, pathologies of the tongue, poor oral hygiene, deep caries, and postnasal drainage are
primarily associated with halitosis,  in which condition, species such as Peptostreptococcus
anaerobius,  Bacteriodes  spp.,  Centipedia  peritontii,  Eubacterium  spp.,  Topbium  parvulum,
Camplyobacter  rectus,  Eikenella  corrodens,  Eubacterium  sulci,  Fusobacterium  nucleatum  or
periodonticum,  Porphyromonas  endodontalis  or  gingivalis,  Solobacterium  moorei,  Bacteriodes
forsythus,  Treponema denticola,  and Streptococcus salivariou  are well-known bacterial strains
responsible for halitosis [5, 6]. Next, pseudohalitosis can be described as a situation where
obvious  malodor  is  not  perceived by others,  but  only  perceived by the  patient,  that  is,
patients  who consider  to  have  bad breath,  but  who does  never  been acknowledged by
others, the patients with pseudo-halitosis often coinciding with depression and anxiety [7].
Finally,  halitophobia  is  a  situation  when  a  patient  complains  about  halitosis  after  the
treatment of  either genuine halitosis  or pseudo-halitosis,  even though no objective clues
were  documented.  Therefore,  patients  with  halitophobia  are  usually  accompanied  with
vague psychiatric disturbance [2]. Although 0.5–1% of the adult population is affected with
halitophobia during their social life,  most patients with halitophobia frequently hop and
hop from clinic/specialist  to  clinic/specialist  in  order  to  find an argument  for  their  self-
esteemed problem [8].
Halitosis relevant with practical clinical problems can be classified into the following two
clinical situations according to origin, one is oral halitosis, around 90% in all, and the other
is extraoral halitosis, remaining 10% among whole halitosis [9]. Since VSCs are responsi‐
ble for halitosis irrespective of origin, in case of extraoral halitosis, VSCs generally generated
from the body, travel to the lung through the vascular system, and pull out through breath
from the alveoli. As another systemic diseases causing extraoral halitosis, liver disease, such
as  cirrhosis,  hepatoma,  and  hepatic  failure,  uremia  from  end-stage  renal  disease,  and
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metabolic disorder,  such as diabetic ketoacidosis and other kinds of  metabolic disorders
had been reported. Also, excess food intake (food factors) like garlic or onion can be common
etiology for halitosis [10, 11]. Among these system diseases, it must be kept in mind that
halitosis can be a clue symptom suggestive of serious cancers, especially gastric, liver, and
pancreatic cancer. Furthermore, halitosis can be one of the prominent extragastric manifes‐
tations suggestive of Helicobacter pylori (H. pylori)–associated ulcer or cancer because of the
evidence showing correlation between VSCs levels and these gastric lesions [12, 13], about
which  detailed  description  will  be  followed.  As  nonoral  cause  of  halitosis,  sinusitis,
tonsillitis,  bronchiectasis,  subphrenic  abscess,  esophageal  diverticulum,  pyloric  stenosis,
gastroesophageal reflux disease (GERD), and hepatitis are very common diseases relevant
to halitosis encountered in clinic.
2. Halitosis provoked by gastrointestinal (GI) diseases
Apart  from  oral  cavity,  the  GI  tract  diseases  caused  halitosis  as  presenting  symptoms,
though physician and patients still abusively believe that halitosis originates from the oral
cavity or stomach. For instance, almost all patients suffering from some erosive changes in
esophago-gastric organ, halitosis might be very common and earliest manifestation. In our
earlier investigation [15], almost all patients with GERD or some degree of erosive gastritis,
real levels of VSCs were significantly increased. Other examples of clinical diseases, such
as pyloric stenosis, duodenal obstruction, aorto-enteric anastomosis, pharyngeal pouches,
Zenker’s diverticulum, and hiatal hernia, usually led to halitosis as usual clinical manifes‐
tations. Especially, GERD, achalasia, or other malabsorption syndromes may cause halitosis
accompanied  with  other  symptoms  of  retching  and  flatulence.  In  cases  of  intestinal
obstruction,  halitosis  may be detectable  because the first  sign noticed to either  patient’s
relatives or physician. Halitosis is usually noted after consuming dietary products, such as
garlic, onions, and some spiced foods cause transient unpleasant odor or halitosis [14]. Yoo
et  al.  [15]  found  that  erosive  changes  in  the  esophago–gastro–duodenal  mucosa  were
significantly correlated with increased levels of VSCs, suggesting that halitosis could be a
symptom suggestive of the erosive diseases of the upper gut mucosa. In detail, as shown
in Figure 1, erosive changes in the esophageal mucosa, erosive type GERD, were strongly
associated with  VSC levels,  ascertaining the  hypothesis  that  halitosis  can be  a  potential
biomarker for the discrimination between erosive GERD and nonerosive GERD, assuring
the presence of erosive change in the lower EG junction [16]. In summary, GI pathology
was  very  common in  patients  with  halitosis  as  extraoral  origin  [17],  approximately  50–
60% among all gastroenterology patients. Conclusively, halitosis symptom, usually ignored
as  insignificant,  should  be  investigated  to  search  for  etiology  even  in  nondental  area.
Accompanied with halitosis, there has been a report [18] describing that H. pylori coloniza‐
tion  of  tongue  mucosa  increased  incidence  of  atrophic  glossitis  and  burning  mouth
syndrome, especially accompanied with halitosis.
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Figure 1. Correlation between EG lesion and halitosis. (A) Halitosis measurement with Halimeter in 72 patients with
halitosis. Significant differences in Halimeter ppb were noted between patients with superficial gastritis and patients
with erosive/ulcerative lesion (p<0.0001) (B) halitosis measurement with gas chromatography (GC) in same 72 patients
with halitosis. Significant differences in VSCs ppm were noted between patients with superficial gastritis and patients
with erosive/ulcerative lesion (p<0.000006). (C) The expressions of CSE and CBA according to EG mucosal changes.
The mean expressions of CBS or CSE were significantly increasingly noted in patients with erosive changes. All of
these results consistently suggested “halitosis” as possible biomarker predicting the presence of mucosal destruction
and resulting putrefactive process in stomach.
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3. Hydrogen sulfide (H2S) biogas: Good, bad, ugly in its biology, and
halitosis
Although biologic gas such as H2S as principal gas molecule is responsible for causing halitosis,
there are contradictory biological implications of three major biogas, nitric oxide (NO), H2S,
and carbon monoxide (CO), in anti-inflammatory substances, promoting resolution of
inflammatory processes, imposing several situations, including ischemic-reperfusion injury,
cardioprotection, sepsis, hemostasis, fibrosis, pancreatitis, separately, but sometimes interact‐
ing each other [19, 20]. Interestingly, H2S stands for dual functions, inflammatory mediator or
anti-inflammatory mediator [21], gaseous intracellular transducer implicated in either
abnormal pathology or normal physiology [22], positioning homeostasis as friend or foe [23].
H2S and their responsible enzymes, cystathionine-β-synthase (CBS) and cystathionine-γ-lyase
(CSE), played good or bad, but ugly biological implications dependent on cellular context and
disease conditions.
Though many new technologies to detect endogenous H2S production and to develop novel
H2S-delivery compounds have been invented [24], simple gas with complex biology of good,
bad, and ugly aspect, in this chapter, the way to detect VSCs, the implication of H2S among
VSCs, and their regulations will be introduced. The Halimeter (Interscan corporation, Chats‐
worth, CA, Figure 1A) and OralChroma (Abimedical corporation, Kanagawa, Japan) are
electronic devices available to detect some of the VSCs in expired air easily in clinic. These two
devices are a portable gas chromatograph featuring easy to handle, lower cost, higher
performance, time saving, fast results, very accurate, and reproducible even compared with
conventional gas chromatographs. However, the limitation is that they limitedly target three
gases: H2S, CH3SH, and (CH3)2S. With the Halimeter measurement, the total amount of VSCs
in parts per billion (ppb) in breathing air is shown. In normal situations, this value is less than
100 ppb. When 300–400 ppb are detected in the mouth air, objective halitosis can be confirmed,
of course, the changes of ppb level can be traced after some interventions to mitigate halitosis
[25]. Though they are rather inexpensive and can be controlled by untrained staff, the limited
diversity in the explored gasses and inconvenienceby examiner’s cooperation should be
further improved. On the other hand, the OralChroma may produce a more comprehensive
assessment of VSCs production by oral microflora compared to Halimeter [26]. Of course, gas
chromatography (GC) analysis can be performed on diverse sources, such as saliva, tongue
debris, aspirated gastric juices, and even biopsied tissues, in addition to breath and almost all
different air components can be detected, golden standard for halitosis, but not easy to measure
and expensive [27]. In expired air, almost 500 different substances can be measured with GC
(Figure 1B). Although GC has been used since the late 1960s, GC is still in an experimental
stage, infrequent use for clinic [28]. Though GC has several advantages, such as an analysis of
almost all components, high sensitivity, specificity, and noninvasive, it is very expensive, hard
to handle because a well-trained staff is mandatory and not portably used [29]. Besides of these
measurements, the scientific and practical value of additional or alternative measurement
methods, such as benzoyl-DL-arginine-naphthylamide (BANA) test, chemical sensors,
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salivary incubation test, quantifying galactosidase activity, ammonia monitoring, Ninhydrin
method, and PCR, has been applied in clinic.
3.1. H2S as dual-edged sword, is it neurotransmitter or inflammatory mediator?
H2S is a well-known toxic gas that is synthesized from the amino acids, cysteine and homo‐
cysteine, by two enzymes, CBS and CSE [30, Figure 1C]. Like other biogas, CO or NO, H2S is
a signaling molecule implicated in either physiological actions of the cardiovascular or
digestive system or pathophysiological actions in homeostasis, proliferation, and apoptosis of
vascular smooth muscle cells, insulin release, nociceptive effects, cytoprotection, but contra‐
dictory action of inflammatory mediators, for instance, pancreatitis, chronic obstructive
pulmonary disease, joint inflammation, sepsis, and H. pylori–associated gastritis in gastroen‐
terology [23, 31–33]. In detail, in pancreatitis, especially in a form of severe acute pancreatitis
(SAP), the fact that treatment with DL-propargylglycine (PAG) induced pancreatic acinar cell
apoptosis and decreased the pathological scores as well as inflammatory parameters, whereas
administration of NaHS significantly aggravated SAP suggested the implication of H2S in
pancreatitis [34]. For instance, Bhatia M et al. [35] published that proinflammatory role of H2S
regulated the severity of pancreatitis and even associated lung injury. On the other hand, in
endotoxemia or sepsis model, H2S contributed to recovery or rescuing actions [36–38].
4. Halitosis as one of extragastric manifestations of H. pylori infection
(Figure 3)
H. pylori was shown to produce H2S and CH3SH, major oral malodor, inducing VSCs, sug‐
gesting that H. pylori can contribute to the development of halitosis relevant with tissue
destruction in the GI tract [12]. The findings that as H. pylori–associated chronic gastritis
worsened, it caused significant increase in levels of VSCs, but significant improvement of
halitosis after eradication signified that halitosis can be overtly correlated with extra-gastric
symptoms of H. pylori infection. Taken together with the additional fact that H. pylori infection
was responsible for diverse oral pathologies [39], there are two liaisons between H. pylori
infection and halitosis, one is that H. pylori can provoke halitosis through oral cavity infection
[40] and the other is that gastric pathologies caused by chronic H. pylori infection are respon‐
sible for halitosis as extragastric manifestation [41]. According to literature search, there were
48 articles reporting the association between saliva/plaque and H. pylori infection. As example
showing association between H. pylori infection and various oral diseases, Tiomny et al. [42]
reported that in Israel, when studied six patients with halitosis and five of whom were H.
pylori positive, the symptoms of halitosis disappeared after successful eradication. Similar
results were reported by Ierardi et al. [43] documented with real measurement of VSC in H.
pylori infection. Serin et al. [44] administered triple eradication therapy to subjects with H.
pylori–positive halitosis and found about two third of patients were free from halitosis, all of
these studies consistently signified that halitosis is a frequent and treatable symptom in H.
pylori–positive chronic gastritis and can be a valid indication for H. pylori eradication. Our
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group extended these investigations, in which any erosive or ulcerative lesions relevant with
H. pylori infection provoked higher rate of halitosis and healing from erosive changes war‐
ranted improvement of halitosis in all subjects, in this study objective measurements as well
as subjective changes of halitosis were done with real value of H2S measured by either gas
chromatography or Halimeter. Recently, it was reported that H. pylori infection increased the
risk of BHH (burning, halitosis, and lingual dorsum hyperplasia). H. pylori detection in the
oral cavity by histopathologic diagnosis and molecular biology was confirmed in 87% patients
with BHH, but only lesser than 2.6% in other kinds of oral diseases [39,45].
 
 
 
Figure 2. Halitosis as possible extragastric manifestation of H. pylori infection and relief with KRG. (A) H. pylori infec‐
tion led to several pathogenic changes in gastric mucosa, oxidative stress, inflammatory mediators, apoptosis, and in‐
creasing expression of CBS and CSE, after which increased H2S seems to be responsible for inflammatory, ulcerative,
and halitosis changes. (B) KRG was identified as natural product controlling CBS or CSE expressions followed with
additional action mechanisms of augmenting eradication, lessening gastric inflammation, and ameliorating halitosis.
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There were two translational studies confirming the association between H. pylori infection
and halitosis through real measurements of VSCs in clinical setting: one was the study by
Suzuki et al. [46] that used saliva from the 25 halitosis patients associated with H. pylori
infection; the clinical symptoms associated with halitosis and periodontal symptoms were
significantly greater in the H. pylori–positive subjects and the other from our author’s group
[15] shows that halitosis could be an effective biomarker in predicting H. pylori–associated
erosive and inflammatory changes, of which were significantly correlated with halitosis
improvement after eradication. Reports regarding the long-term outcome that eradication of
H. pylori in patients with functional dyspepsia warranted sustained improvement of halitosis
were available [47] and they strongly supported the existence of a close link between H.
pylori infection and halitosis. Conclusively H. pylori eradication should be considered in
patients with troublesome halitosis, bothering patients with limited social activities due to
halitosis (Figure 2A).
5. Amelioration of troublesome halitosis through suppressing H. pylori–
associated H2S with natural products
Lee et al [41] investigated 88 patients with functional dyspepsia presenting with halitosis, all
of them showed very high levels of Halimeter >100 ppb, on whom tests were repeated after 10
weeks of Korean red ginseng (KRG) administration. As results, most patients with successful
eradication of H. pylori benefited with subjective and objective improvement of halitosis. Before
the current clinical trials, positive outcomes were anticipated in in vitro investigation that KRG
extracts significantly decreased H. pylori- or NaHS-induced CSE expressions concomitant with
attenuated levels of H2S, IL-6, IL-8, as well as IL-1β mRNA. The findings that more than half
of the cases (52.3–65.0%) became free of halitosis with KRG treatment alone, but it was the
combination of a successful eradication regimen with KRG supplementation accompanied
with in vitro proof showing KRG was very effective in suppressing the CSE/CBS gene led to
the following conclusion: H. pylori infection might be closely responsible for halitosis and KRG
supplementation was proven to be very effective in relieving halitosis in addition to being
responsible for bacterial suppression (Figure 2B). In addition, generally good short-term
results were reported with chlorhexidine. Triclosan seems less effective, essential oils and
cetylpyridinium chloride are only effective up to 2 or 3 hours. Metal ions and oxidizing agents,
such as hydrogen peroxide, chlorine dioxide, and iminium, are active in neutralizing volatile
sulfur-containing compounds [48,49], but these are only for lessening halitosis not removing
etiopathogenic background.
In conclusion, though the solution of halitosis problems must include the reduction of the
intraoral bacterial load and/or the conversion of VSCs to nonvolatile substrates [50], targeting
both etiologic organism removal and VSCs generating enzyme suppression seems to be very
ideal modality of halitosis treatment (Figure 3), in which KRG seems to ideal product to deserve
in clinic.
Extradigestive Manifestations of Helicobacter Pylori Infection - An Overview24
H
2
S
Vasodilatation
Hypoxia
Leukocyte adhesion 
Inflammations
Necrosis
NF-κB activations
COX-2/iNOS
MAPKs
NOXs
Inflammations
Oxidative stress
Apoptosis
AP-1/CREB activations
Cytokines/chemokines
eNOS
Cell adhesion molecules
Halitosis/
GERD/ Gastric erosions/ Gastric ulcers/ Gastric cancer
CSE /CBS
Homocysteine 
Cystathione 
L-Cysteine
Helicobacter pylori
Gastric epithelial cells
CBS
CSE
H
2
S
H
2
S
Endothelial cells
Leukocytes
Figure 3. H. pylorii infection caused halitosis as well as overt clinical diseases relevant to H2S generation Dietary sour‐
ces of L-cysteine and H. pylori infection provoked CBS/CSE activations, leading to increased H2S generation. Currently
dual edged biological actions of H2S were reported; one was vasodilatation and antioxidative actions, and the other the
aggravation of inflammations and hypoxic condition. In the stomach under H. pylori infection, H2S-driven gastric sur‐
face destruction as well as gastritis finally rendered gastric diseases such as erosive gastritis or ulcerative lesions. Also
halitosis was significantly manifested as extragastric symptoms associated with H. pylori infection due to significant
associations and amelioration of halitosis after eradication.
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